WHO ICTRP trial
The warning effect of Decoy Receptor 3 (DcR3) on new sepsis after surgery and…
ChiCTR2000039262 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000039262 |
|---|---|
| Public title | The warning effect of Decoy Receptor 3 (DcR3) on new sepsis after surgery and its related cellular immune mechanism |
| Scientific title | The warning effect of Decoy Receptor 3 (DcR3) on new sepsis after surgery and its related cellular immune mechanism |
| Primary sponsor | Beijing Chaoyang Hospital Affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Sepsis |
| Interventions | sepsis group:Nil;non-sepsis group:Nil |
| Registration date | Oct 22, 2020 |
| Target size | sepsis group:90;non-sepsis group:90 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: